Product description
Specifications 1.Factory direct
2.Price advantage
3.Good safety
4.GMP certificate
1. Approved in Europe and many non-European countries,Hydroxyethyl starch 130/0.4 s the clinical newest and most cutting-edge plasma substitutes. 2. The perfect combination among the molecular weight hydroxyethyl starch, molar substitution and C2/C6 ratio makes 100% of plasma expansion effect. Hydroxyethyl starch 130/0.4 produces less adverse reactions, safe and satisfactory, representing the highest level of the current plasma substitutes. 3. Hydroxyethyl starch 130/0.4 belongs to national health insurance B. This product is first listing in the domestic market. It has huge market capacity, maturely academic theory and easy mass production.